<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Granulocyte-Specific | BB</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="This section focuss attention on the surface markers of another critical blood cell: the granulocyte, particularly the neutrophil. Just as red cells and platelets have their unique antigen...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Granulocyte-Specific | BB">
<meta property="og:type" content="book">
<meta property="og:description" content="This section focuss attention on the surface markers of another critical blood cell: the granulocyte, particularly the neutrophil. Just as red cells and platelets have their unique antigen...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Granulocyte-Specific | BB">
<meta name="twitter:description" content="This section focuss attention on the surface markers of another critical blood cell: the granulocyte, particularly the neutrophil. Just as red cells and platelets have their unique antigen...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="icon" type="image/png" href="imgs/favicon.png">
<meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
<link rel="stylesheet" href="toc.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Blood Bank</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Blood Products</li>
<li><a class="" href="donors.html">Donors</a></li>
<li><a class="" href="qualification.html">Qualification</a></li>
<li><a class="" href="processing.html">Processing</a></li>
<li><a class="" href="adverse-reactions-1.html">Adverse Reactions</a></li>
<li><a class="" href="special-donations-1.html">Special Donations</a></li>
<li><a class="" href="processing-1.html">Processing</a></li>
<li><a class="" href="fda-aabb-requirements.html">FDA, AABB Requirements</a></li>
<li><a class="" href="testing.html">Testing</a></li>
<li><a class="" href="labeling.html">Labeling</a></li>
<li><a class="" href="storage.html">Storage</a></li>
<li><a class="" href="anticoagulantsadditives.html">Anticoagulants/Additives</a></li>
<li><a class="" href="temperature-requirements.html">Temperature Requirements</a></li>
<li><a class="" href="transportation.html">Transportation</a></li>
<li><a class="" href="stored-products.html">Stored Products</a></li>
<li><a class="" href="expiration.html">Expiration</a></li>
<li><a class="" href="blood-components.html">Blood Components</a></li>
<li><a class="" href="red-blood-cells.html">Red Blood Cells</a></li>
<li><a class="" href="cryoprecipitated-ahf.html">Cryoprecipitated AHF</a></li>
<li><a class="" href="platelets.html">Platelets</a></li>
<li><a class="" href="plasma.html">Plasma</a></li>
<li><a class="" href="granulocytes.html">Granulocytes</a></li>
<li><a class="" href="wbc-reduced-components.html">WBC-Reduced Components</a></li>
<li><a class="" href="frozendeglycerolized-rbcs.html">Frozen/Deglycerolized RBCs</a></li>
<li><a class="" href="apheresis-products.html">Apheresis Products</a></li>
<li><a class="" href="fractionation-products.html">Fractionation Products</a></li>
<li><a class="" href="whole-blood.html">Whole Blood</a></li>
<li><a class="" href="washed-rbcs.html">Washed RBCs</a></li>
<li><a class="" href="rejuvenated-rbcs.html">Rejuvenated RBCs</a></li>
<li><a class="" href="irradiated-components.html">Irradiated Components</a></li>
<li><a class="" href="hematopoietic-progenitors.html">Hematopoietic Progenitors</a></li>
<li><a class="" href="blood-component-qc.html">Blood Component QC</a></li>
<li class="book-part">Blood Group Systems</li>
<li><a class="" href="genetics.html">Genetics</a></li>
<li><a class="" href="basic.html">Basic</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="blood-group-inheritance.html">Blood Group Inheritance</a></li>
<li><a class="" href="biochemistryantigens.html">Biochemistry/Antigens</a></li>
<li><a class="" href="abo.html">ABO</a></li>
<li><a class="" href="lewis.html">Lewis</a></li>
<li><a class="" href="rh.html">Rh</a></li>
<li><a class="" href="mns.html">MNS</a></li>
<li><a class="" href="p1pkglobosidep.html">P1PK/Globoside(P)</a></li>
<li><a class="" href="ii.html">Ii</a></li>
<li><a class="" href="kell.html">Kell</a></li>
<li><a class="" href="kidd.html">Kidd</a></li>
<li><a class="" href="duffy.html">Duffy</a></li>
<li><a class="" href="lutheran.html">Lutheran</a></li>
<li><a class="" href="other-blood-groups.html">Other Blood Groups</a></li>
<li><a class="" href="high-prevalence-antigens.html">High Prevalence Antigens</a></li>
<li><a class="" href="low-prevalence-antigens.html">Low Prevalence Antigens</a></li>
<li><a class="" href="hla.html">HLA</a></li>
<li><a class="" href="platelet-specific.html">Platelet-Specific</a></li>
<li><a class="active" href="granulocyte-specific.html">Granulocyte-Specific</a></li>
<li><a class="" href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></li>
<li><a class="" href="immunogenicity.html">Immunogenicity</a></li>
<li><a class="" href="antigen-prevalence.html">Antigen Prevalence</a></li>
<li class="book-part">Immunology &amp; Physiology</li>
<li><a class="" href="immunology.html">Immunology</a></li>
<li><a class="" href="immune-response.html">Immune response</a></li>
<li><a class="" href="primary-secondary.html">Primary &amp; Secondary</a></li>
<li><a class="" href="b-t-cells-macrophages.html">B &amp; T cells, Macrophages</a></li>
<li><a class="" href="genetics-1.html">Genetics</a></li>
<li><a class="" href="immunoglobulins.html">Immunoglobulins</a></li>
<li><a class="" href="classes-subclasses.html">Classes &amp; Subclasses</a></li>
<li><a class="" href="structure.html">Structure</a></li>
<li><a class="" href="properties.html">Properties</a></li>
<li><a class="" href="ag-ab-interactions.html">Ag-Ab Interactions</a></li>
<li><a class="" href="principles.html">Principles</a></li>
<li><a class="" href="testing-1.html">Testing</a></li>
<li><a class="" href="complement.html">Complement</a></li>
<li><a class="" href="pathway-mechanisms.html">Pathway Mechanisms</a></li>
<li><a class="" href="biologic-properties.html">Biologic Properties</a></li>
<li><a class="" href="physiology-pathophysiology.html">Physiology &amp; Pathophysiology</a></li>
<li><a class="" href="blood-physiology.html">Blood Physiology</a></li>
<li><a class="" href="circulation-volume.html">Circulation &amp; Volume</a></li>
<li><a class="" href="composition-function.html">Composition &amp; Function</a></li>
<li><a class="" href="cell-survival.html">Cell Survival</a></li>
<li><a class="" href="cell-metabolism.html">Cell Metabolism</a></li>
<li><a class="" href="hemostasis-coagulation.html">Hemostasis &amp; Coagulation</a></li>
<li><a class="" href="factors-disorders.html">Factors &amp; Disorders</a></li>
<li><a class="" href="plt-functions-disorders.html">PLT Functions &amp; Disorders</a></li>
<li><a class="" href="hdfn.html">HDFN</a></li>
<li><a class="" href="pathophysiology.html">Pathophysiology</a></li>
<li><a class="" href="detection.html">Detection</a></li>
<li><a class="" href="treatment.html">Treatment</a></li>
<li><a class="" href="prevention.html">Prevention</a></li>
<li><a class="" href="cytopenias-1.html">Cytopenias</a></li>
<li><a class="" href="anemia.html">Anemia</a></li>
<li><a class="" href="thrombocytopenia.html">Thrombocytopenia</a></li>
<li><a class="" href="neutropenia.html">Neutropenia</a></li>
<li><a class="" href="transplantation-1.html">Transplantation</a></li>
<li><a class="" href="solid-organ.html">Solid Organ</a></li>
<li><a class="" href="hpc.html">HPC</a></li>
<li class="book-part">Serology &amp; Molecular</li>
<li><a class="" href="routine-tests.html">Routine Tests</a></li>
<li><a class="" href="blood-grouping.html">Blood Grouping</a></li>
<li><a class="" href="compatibility.html">Compatibility</a></li>
<li><a class="" href="antibody-detection.html">Antibody Detection</a></li>
<li><a class="" href="crossmatch.html">Crossmatch</a></li>
<li><a class="" href="ab-id-significance.html">Ab ID &amp; Significance</a></li>
<li><a class="" href="dat.html">DAT</a></li>
<li><a class="" href="reagents.html">Reagents</a></li>
<li><a class="" href="antiglobulin-sera.html">Antiglobulin Sera</a></li>
<li><a class="" href="blood-grouping-sera.html">Blood Grouping Sera</a></li>
<li><a class="" href="reagent-rbcs.html">Reagent RBCs</a></li>
<li><a class="" href="special-tests-reagents.html">Special Tests &amp; Reagents</a></li>
<li><a class="" href="enzymes.html">Enzymes</a></li>
<li><a class="" href="enhancement-media.html">Enhancement Media</a></li>
<li><a class="" href="lectins.html">Lectins</a></li>
<li><a class="" href="adsorptions.html">Adsorptions</a></li>
<li><a class="" href="elutions.html">Elutions</a></li>
<li><a class="" href="titrations-1.html">Titrations</a></li>
<li><a class="" href="cell-separations.html">Cell Separations</a></li>
<li><a class="" href="elisa.html">ELISA</a></li>
<li><a class="" href="molecular-techniques.html">Molecular Techniques</a></li>
<li><a class="" href="neutralization.html">Neutralization</a></li>
<li><a class="" href="thiol-reagents.html">Thiol Reagents</a></li>
<li><a class="" href="immunofluorescence.html">Immunofluorescence</a></li>
<li><a class="" href="solid-phase.html">Solid Phase</a></li>
<li><a class="" href="column-agglutination.html">Column Agglutination</a></li>
<li><a class="" href="chloroquine-diphosphate.html">Chloroquine Diphosphate</a></li>
<li><a class="" href="edta-glycine-acid.html">EDTA-Glycine Acid</a></li>
<li><a class="" href="quality-assurance.html">Quality Assurance</a></li>
<li><a class="" href="blood-samples.html">Blood Samples</a></li>
<li><a class="" href="reagents-1.html">Reagents</a></li>
<li><a class="" href="test-procedures.html">Test Procedures</a></li>
<li class="book-part">Transfusion Practice</li>
<li><a class="" href="indications.html">Indications</a></li>
<li><a class="" href="component-therapy.html">Component Therapy</a></li>
<li><a class="" href="adverse-effects.html">Adverse Effects</a></li>
<li><a class="" href="immunologic.html">Immunologic</a></li>
<li><a class="" href="nonimmunologic.html">Nonimmunologic</a></li>
<li><a class="" href="ttds.html">TTDs</a></li>
<li><a class="" href="apheresis-extracorporeal-circulation.html">Apheresis &amp; Extracorporeal Circulation</a></li>
<li><a class="" href="blood-administration-patient-blood-management.html">Blood Administration &amp; Patient Blood Management</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="granulocyte-specific" class="section level1 unnumbered">
<h1>Granulocyte-Specific<a class="anchor" aria-label="anchor" href="#granulocyte-specific"><i class="fas fa-link"></i></a>
</h1>
<p>This section focuss attention on the surface markers of another critical blood cell: the granulocyte, particularly the neutrophil. Just as red cells and platelets have their unique antigen systems, neutrophils possess their own set of polymorphic surface proteins known as <strong>Human Neutrophil Antigens (HNA)</strong>. Distinct from HLA, HPA, or traditional red cell antigens, these HNAs play roles in neutrophil function. While not routinely typed in the blood bank, understanding HNAs is vital because antibodies directed against them are significant causes of serious conditions like Transfusion-Related Acute Lung Injury (TRALI) and immune-mediated neutropenias</p>
<div id="hna-markers-on-the-immune-systems-first-responders" class="section level2 unnumbered">
<h2>
<strong>HNA: Markers on the Immune System’s First Responders</strong><a class="anchor" aria-label="anchor" href="#hna-markers-on-the-immune-systems-first-responders"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>What are they?:</strong> HNAs are polymorphic (variable between individuals) antigens expressed on the surface membranes of neutrophils and sometimes other granulocytes (eosinophils, basophils) or monocytes</li>
<li>
<strong>Distinction from HLA/HPA/RBC Antigens:</strong> HNAs are distinct molecular structures located on different proteins compared to HLA (found on almost all nucleated cells + platelets), HPA (platelets), or RBC antigens. However, neutrophils <em>also</em> express HLA Class I antigens</li>
<li>
<strong>Primary Clinical Relevance:</strong> Antibodies to HNAs are primarily implicated in:
<ul>
<li><strong>Transfusion-Related Acute Lung Injury (TRALI)</strong></li>
<li><strong>Neonatal Alloimmune Neutropenia (NAN)</strong></li>
<li><strong>Autoimmune Neutropenia (AIN)</strong></li>
<li>Febrile Non-Hemolytic Transfusion Reactions (FNHTR - less common now with universal leukoreduction)</li>
<li>Immune-mediated refractoriness to granulocyte transfusions (rarely used)</li>
</ul>
</li>
</ul>
</div>
<div id="biochemistry-where-hnas-live" class="section level2 unnumbered">
<h2>
<strong>Biochemistry: Where HNAs Live</strong><a class="anchor" aria-label="anchor" href="#biochemistry-where-hnas-live"><i class="fas fa-link"></i></a>
</h2>
<p>HNA antigens are located on various neutrophil membrane glycoproteins, many involved in immune function like adhesion, phagocytosis, and signaling:</p>
<ul>
<li>
<strong>Fcγ Receptor IIIb (FcγRIIIb or CD16b):</strong> This receptor binds the Fc portion of IgG antibodies, playing a role in antibody-dependent cell-mediated cytotoxicity (ADCC) and phagocytosis. It’s attached to the membrane via a <strong>GPI anchor</strong>
<ul>
<li>Carries the <strong>HNA-1</strong> system antigens (HNA-1a, HNA-1b, HNA-1c)</li>
</ul>
</li>
<li>
<strong>CD177:</strong> A GPI-anchored protein whose function is not fully elucidated but seems involved in neutrophil migration and adhesion. Expression is variable among individuals – some people have neutrophils that lack CD177 entirely
<ul>
<li>Carries the <strong>HNA-2</strong> system antigen (HNA-2a). Individuals lacking CD177 are HNA-2 null</li>
</ul>
</li>
<li>
<strong>Choline Transporter-Like Protein 2 (CTL2):</strong> A transmembrane protein
<ul>
<li>Carries the <strong>HNA-3</strong> system antigens (HNA-3a, HNA-3b). The HNA-3a polymorphism causes a significant structural change</li>
</ul>
</li>
<li>
<strong>Other Glycoproteins:</strong> HNA-4 and HNA-5 systems are located on other glycoproteins (integrin αM/CD11b for HNA-4a, and integrin αL/CD11a for HNA-5a)</li>
</ul>
</div>
<div id="genetics-and-nomenclature-1" class="section level2 unnumbered">
<h2>
<strong>Genetics and Nomenclature</strong><a class="anchor" aria-label="anchor" href="#genetics-and-nomenclature-1"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Nomenclature:</strong> Uses “HNA” followed by a number for the system/locus and a letter (a, b, c) for the specific allele/antigen (e.g., HNA-1a, HNA-1b)</li>
<li>
<strong>Inheritance:</strong> Inherited as Mendelian codominant traits</li>
<li>
<strong>Polymorphism:</strong> Arise from SNPs in the genes encoding the carrier glycoproteins, leading to amino acid changes</li>
</ul>
</div>
<div id="major-clinically-significant-hna-systems" class="section level2 unnumbered">
<h2>
<strong>Major Clinically Significant HNA Systems</strong><a class="anchor" aria-label="anchor" href="#major-clinically-significant-hna-systems"><i class="fas fa-link"></i></a>
</h2>
<div class="inline-table"><table class="table table-sm">
<colgroup>
<col width="3%">
<col width="13%">
<col width="11%">
<col width="20%">
<col width="50%">
</colgroup>
<thead><tr class="header">
<th align="left">System</th>
<th align="left">Carrier Molecule (Protein)</th>
<th align="left">Alleles/Antigens</th>
<th align="left">Approx. Caucasian Freq. (Highly Variable)</th>
<th align="left">Key Clinical Significance (Antibody)</th>
</tr></thead>
<tbody>
<tr class="odd">
<td align="left"><strong>HNA-1</strong></td>
<td align="left">FcγRIIIb (CD16b)</td>
<td align="left">HNA-1a, HNA-1b, HNA-1c</td>
<td align="left">1a (~35-45%), 1b (~55-65%), 1c (rare)</td>
<td align="left">Anti-HNA-1a, -1b implicated in TRALI, NAN, AIN, FNHTR.</td>
</tr>
<tr class="even">
<td align="left"><strong>HNA-2</strong></td>
<td align="left">CD177</td>
<td align="left">HNA-2a (NB1)</td>
<td align="left">Present (~95-97%), Null (~3-5%)</td>
<td align="left">Anti-HNA-2a implicated in severe TRALI, NAN, AIN. Can only be formed by HNA-2 null individuals.</td>
</tr>
<tr class="odd">
<td align="left"><strong>HNA-3</strong></td>
<td align="left">CTL2</td>
<td align="left">HNA-3a, HNA-3b</td>
<td align="left">3a (~75-85%), 3b (~15-25%)</td>
<td align="left">
<strong>Anti-HNA-3a</strong> strongly associated with <strong>severe, often fatal TRALI</strong>. Anti-HNA-3b less common/severe.</td>
</tr>
<tr class="even">
<td align="left"><strong>HNA-4</strong></td>
<td align="left">CD11b (Integrin αM)</td>
<td align="left">HNA-4a</td>
<td align="left">&gt;99%</td>
<td align="left">Anti-HNA-4a implicated in AIN, rare TRALI/NAN.</td>
</tr>
<tr class="odd">
<td align="left"><strong>HNA-5</strong></td>
<td align="left">CD11a (Integrin αL)</td>
<td align="left">HNA-5a</td>
<td align="left">~98%</td>
<td align="left">Anti-HNA-5a implicated in TRALI, AIN.</td>
</tr>
</tbody>
</table></div>
<p><em>Note: Frequencies vary significantly across ethnic groups. HNA-1c is primarily found in individuals of African descent</em></p>
</div>
<div id="clinical-significance-the-impact-of-hna-antibodies" class="section level2 unnumbered">
<h2>
<strong>Clinical Significance: The Impact of HNA Antibodies</strong><a class="anchor" aria-label="anchor" href="#clinical-significance-the-impact-of-hna-antibodies"><i class="fas fa-link"></i></a>
</h2>
<div id="trali-transfusion-related-acute-lung-injury" class="section level3 unnumbered">
<h3>
<strong>TRALI (Transfusion-Related Acute Lung Injury)</strong><a class="anchor" aria-label="anchor" href="#trali-transfusion-related-acute-lung-injury"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Mechanism:</strong> This is where HNAs have their biggest transfusion medicine impact today. Donor plasma containing <strong>high-titer HNA antibodies</strong> (or HLA Class II antibodies) transfused to a recipient whose neutrophils express the corresponding antigen. The antibodies activate the recipient’s neutrophils, particularly in the lung vasculature, leading to capillary damage, fluid leakage into the alveoli, and acute respiratory distress. <strong>Anti-HNA-3a</strong> is particularly notorious for causing severe TRALI</li>
<li>
<strong>Mitigation:</strong> Identifying implicated donors and deferring them from donating plasma-rich components. TRALI risk reduction strategies (e.g., using plasma from males, never-pregnant females, or tested females). <em>Leukoreduction of components does NOT prevent antibody-mediated TRALI</em>
</li>
</ul>
</div>
<div id="neonatal-alloimmune-neutropenia-nan" class="section level3 unnumbered">
<h3>
<strong>Neonatal Alloimmune Neutropenia (NAN)</strong><a class="anchor" aria-label="anchor" href="#neonatal-alloimmune-neutropenia-nan"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Mechanism:</strong> Analogous to HDFN and NAIT. Mother lacks an HNA antigen that the fetus inherits from the father. Maternal IgG anti-HNA antibodies cross the placenta and destroy fetal neutrophils</li>
<li>
<strong>Consequences:</strong> Causes neutropenia (low neutrophil count) in the newborn, increasing susceptibility to bacterial infections, often presenting as delayed cord separation, skin infections, or sepsis. Usually less severe than NAIT</li>
<li>
<strong>Management:</strong> Supportive care, antibiotics for infections. Sometimes G-CSF (Granulocyte Colony-Stimulating Factor) to boost neutrophil production. Rarely requires granulocyte transfusion (which would need to be antigen-negative)</li>
</ul>
</div>
<div id="autoimmune-neutropenia-ain" class="section level3 unnumbered">
<h3>
<strong>Autoimmune Neutropenia (AIN)</strong><a class="anchor" aria-label="anchor" href="#autoimmune-neutropenia-ain"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Mechanism:</strong> Patients develop <strong>autoantibodies</strong> against their own HNA antigens, leading to neutrophil destruction. Can be primary (idiopathic) or secondary to other conditions (e.g., autoimmune diseases, infections, drugs)</li>
<li>
<strong>Consequences:</strong> Increased risk of infections</li>
<li>
<strong>Management:</strong> Often resolves spontaneously in children (AIN of infancy). May require antibiotics, G-CSF in severe cases</li>
</ul>
</div>
<div id="febrile-non-hemolytic-transfusion-reactions-fnhtr" class="section level3 unnumbered">
<h3>
<strong>Febrile Non-Hemolytic Transfusion Reactions (FNHTR)</strong><a class="anchor" aria-label="anchor" href="#febrile-non-hemolytic-transfusion-reactions-fnhtr"><i class="fas fa-link"></i></a>
</h3>
<ul>
<li>
<strong>Mechanism:</strong> Recipient antibodies reacting with HNA (or HLA) antigens on donor leukocytes in the transfused component, or cytokines released from leukocytes during storage</li>
<li>
<strong>Mitigation:</strong> Largely prevented by universal <strong>leukoreduction</strong> of blood components</li>
</ul>
</div>
</div>
<div id="hna-antibodies" class="section level2 unnumbered">
<h2>
<strong>HNA Antibodies</strong><a class="anchor" aria-label="anchor" href="#hna-antibodies"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Formation:</strong> Alloimmunization occurs via pregnancy or transfusion. Autoantibodies occur in AIN</li>
<li>
<strong>Type:</strong> Primarily <strong>IgG</strong>
</li>
<li>
<strong>Detection:</strong> Challenging! Requires specialized tests not performed in routine blood banks</li>
</ul>
</div>
<div id="hna-testing" class="section level2 unnumbered">
<h2>
<strong>HNA Testing</strong><a class="anchor" aria-label="anchor" href="#hna-testing"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>Performed in specialized reference laboratories (e.g., Platelet &amp; Neutrophil Immunology labs)</li>
<li>
<strong>Methods</strong>
<ul>
<li>
<strong>Serological:</strong> Granulocyte Agglutination Test (GAT), Granulocyte Immunofluorescence Test (GIFT) using flow cytometry. Requires viable neutrophils</li>
<li>
<strong>Molecular (Genotyping):</strong> DNA-based methods to determine HNA types. Increasingly used due to difficulty of serology</li>
</ul>
</li>
<li>
<strong>Challenges:</strong> Neutrophils are fragile, assays can be complex and less standardized than RBC or platelet testing</li>
</ul>
</div>
<div id="key-takeaways" class="section level2 unnumbered">
<h2>
<strong>Key Takeaways</strong><a class="anchor" aria-label="anchor" href="#key-takeaways"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>HNAs are antigens primarily on neutrophils</li>
<li>Antibodies to HNAs are key players in <strong>TRALI</strong> (especially anti-HNA-3a), <strong>Neonatal Alloimmune Neutropenia (NAN)</strong>, and Autoimmune Neutropenia (AIN)</li>
<li>Testing is specialized and complex</li>
<li>Understanding HNAs helps explain specific transfusion reactions and immune cytopenias not attributable to RBC, platelet, or HLA antibodies alone</li>
</ul>
</div>
<div id="key-terms-45" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-45"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>HNA (Human Neutrophil Antigen):</strong> Polymorphic antigens located primarily on the surface of neutrophils (granulocytes)</li>
<li>
<strong>Neutrophil:</strong> A type of granulocyte (white blood cell) that is a primary component of the innate immune system, crucial for fighting bacterial infections</li>
<li>
<strong>TRALI (Transfusion-Related Acute Lung Injury):</strong> A serious transfusion reaction characterized by acute respiratory distress, often caused by donor antibodies (HNA or HLA) activating recipient neutrophils in the lungs</li>
<li>
<strong>NAN (Neonatal Alloimmune Neutropenia):</strong> A condition where maternal IgG anti-HNA antibodies cross the placenta and destroy fetal neutrophils, leading to neutropenia and infection risk in the newborn</li>
<li>
<strong>AIN (Autoimmune Neutropenia):</strong> A condition where an individual produces autoantibodies against their own neutrophils, leading to neutrophil destruction and increased infection risk</li>
<li>
<strong>Fcγ Receptor IIIb (FcγRIIIb / CD16b):</strong> An IgG receptor on neutrophils that carries HNA-1 antigens</li>
<li>
<strong>CD177:</strong> A neutrophil glycoprotein that carries the HNA-2a antigen</li>
<li>
<strong>CTL2 (Choline Transporter-Like Protein 2):</strong> A transmembrane protein carrying HNA-3 antigens</li>
<li>
<strong>GPI Anchor (Glycosylphosphatidylinositol anchor):</strong> A glycolipid structure attaching certain proteins (like FcγRIIIb and CD177) to the cell membrane</li>
<li>
<strong>Leukoreduction:</strong> The process of removing white blood cells from blood components, effective in reducing FNHTR risk but not antibody-mediated TRALI</li>
<li>
<strong>G-CSF (Granulocyte Colony-Stimulating Factor):</strong> A medication used to stimulate the bone marrow to produce more neutrophils, sometimes used to treat NAN or severe AIN</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  sections = [];
  topics = [];
  function hide_label() {
    // sections
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          elem.classList
          .contains('book-part')
          ? sections.push(elem)
          : '';
      });

    // topics
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? topics.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    // sections
    count_sections = 0;
    prev_sections_elem = '';
    sections
      .forEach((elem) => {
      if(count_sections === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_sections = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_sections_elem.classList.add('hide_label');
        } else {
          prev_sections_elem.classList.remove('hide_label');
        }
      }
      prev_sections_elem = elem;
    });
    // topics
    count_topics = 0;
    prev_topic_elem = '';
    topics
      .forEach((elem) => {
      if(count_topics === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count_topics = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_topic_elem.classList.add('hide_label');
        } else {
          prev_topic_elem.classList.remove('hide_label');
        }
      }
      prev_topic_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="platelet-specific.html">Platelet-Specific</a></div>
<div class="next"><a href="role-of-blood-groups-in-transfusion.html">Role of Blood Groups in Transfusion</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#granulocyte-specific">Granulocyte-Specific</a></li>
<li><a class="nav-link" href="#hna-markers-on-the-immune-systems-first-responders">HNA: Markers on the Immune System’s First Responders</a></li>
<li><a class="nav-link" href="#biochemistry-where-hnas-live">Biochemistry: Where HNAs Live</a></li>
<li><a class="nav-link" href="#genetics-and-nomenclature-1">Genetics and Nomenclature</a></li>
<li><a class="nav-link" href="#major-clinically-significant-hna-systems">Major Clinically Significant HNA Systems</a></li>
<li>
<a class="nav-link" href="#clinical-significance-the-impact-of-hna-antibodies">Clinical Significance: The Impact of HNA Antibodies</a><ul class="nav navbar-nav">
<li><a class="nav-link" href="#trali-transfusion-related-acute-lung-injury">TRALI (Transfusion-Related Acute Lung Injury)</a></li>
<li><a class="nav-link" href="#neonatal-alloimmune-neutropenia-nan">Neonatal Alloimmune Neutropenia (NAN)</a></li>
<li><a class="nav-link" href="#autoimmune-neutropenia-ain">Autoimmune Neutropenia (AIN)</a></li>
<li><a class="nav-link" href="#febrile-non-hemolytic-transfusion-reactions-fnhtr">Febrile Non-Hemolytic Transfusion Reactions (FNHTR)</a></li>
</ul>
</li>
<li><a class="nav-link" href="#hna-antibodies">HNA Antibodies</a></li>
<li><a class="nav-link" href="#hna-testing">HNA Testing</a></li>
<li><a class="nav-link" href="#key-takeaways">Key Takeaways</a></li>
<li><a class="nav-link" href="#key-terms-45">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/blob/main/Rmd/02-B-16.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Blood-Bank/blob/edit/main/Rmd/02-B-16.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->


</body>
</html>
